Concepts of comorbidities, multiple morbidities, complications, and their clinical epidemiologic analogs

Clinical Epidemiology

Volumn 5, Issue 1, 2013, Pages 199-203

  Gulbech Ording, Anne ^a   Toft Sørensen, Henrik ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Comorbidity; Complications; Diagnosis related groups; Epidemiologic methods; Epidemiology; Risk adjustment

Indexed keywords

ARTICLE; CAUSAL MODELING; CHARLSON COMORBIDITY INDEX; COMORBIDITY; COMPLICATION; CONFOUNDING VARIABLE; DISEASE DURATION; DISEASE SEVERITY; EPIDEMIOLOGY; HUMAN; MEDICAL RESEARCH; METHODOLOGY; MORBIDITY; MULTIPLE MORBIDITY; NOMENCLATURE; PREDICTION; PROGNOSIS;

EID: 84879707898     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/CLEP.S45305     Document Type: Article

References (33)

1. United Nations. Department of Economic and Social Affairs. Population Division. World Population Ageing 1950-2050. New York, NY: United Nations; 2002.
2. Salive ME. Multimorbidity in older adults. Epidemiol Rev. January 31, 2013. [Epub ahead of print.]
3. Salisbury C. Multimorbidity: redesigning health care for people who use it. Lancet. 2012;380(9836):7-9.
4. Valderas JM, Starfeld B, Sibbald B, Salisbury C, Roland M. Defning comorbidity: implications for understanding health and health services. Ann Fam Med. 2009;7(4):357-363.
5. Marengoni A, Angleman S, Melis R, et al. Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev. 2011;10(4): 430-439.
6. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8-27.
7. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
8. Feinstein AR. The pre-therapeutic classifcation of co-morbidity in chronic disease. J Chronic Dis. 1970;23(7):455-468.
9. Kaplan MH, Feinstein AR. The importance of classifying initial co-morbidity in evaluation the outcome of diabetes mellitus. J Chronic Dis. 1974;27(7-8):387-404.
10. Parkerson GR Jr, Broadhead WE, Tse CK. The Duke Severity of Illness Checklist (DUSOI) for measurement of severity and comorbidity. J Clin Epidemiol. 1993;46(4):379-393.
11. Verbrugge LM, Lepkowski JM, Imanaka Y. Comorbidity and its impact on disability. Milbank Q. 1989;67(3-4):450-484.
12. Linn BS, Linn M W, Gurel L. Cumulative illness rating scale. J Am Geriatr Soc. 1968;16(5):622-626.
13. Greenfeld S, Apolone G, McNeil BJ, Cleary PD. The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement. Med Care. 1993;31(2):141-154.
14. De Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity: a critical review of available methods. J Clin Epidemiol. 2003;56(3):221-229.
15. Rothman KJ. Epidemiology: An Introduction. 2nd ed. Oxford, UK: Oxford University Press; 2012.
16. Schafer I, Hansen H, Schon G, et al. The influence of age, gender and socio-economic status on multimorbidity patterns in primary care. First results from the Multicare Cohort Study. BMC Health Serv Res. 2012;12:89.
17. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med. 1993;328(23):1676-1685.
18. Owens WD, Felts JA, Spitznagel EL Jr. ASA physical status classif-cations: a study of consistency of ratings. Anesthesiology. 1978;49(4): 239-243.
19. Knaus WA, Draper EA, Wagner D P, Zimmerman JE. APACHE II: a severity of disease classifcation system. Crit Care Med. 1985;13(10): 818-829.
20. Knaus W, Wagner D, Draper E. APACHE III study design: analytic plan for evaluation of severity and outcome in intensive care unit patients. Development of APACHE. Crit Care Med. 1989;17(12 Pt 2): S181-S185.
21. Fetter RB, Shin Y, Freeman JL, Averill R F, Thompson JD. Case mix definition by diagnosis-related groups. Med Care. 1980;18(Suppl 2):iii, 1-53.
22. Goldfeld N. The evolution of diagnosis-related groups (DRGs): from its beginnings in case-mix and resource use theory, to its implementation for payment and now for its current utilization for quality within and outside the hospital. Qual Manag Health Care. 2010;19(1):3-16.
23. Rothman KJ, Greenland S, Lash T. Validity in epidemiologic studies. In: Modern Epidemiology. 3rd ed. Philadelphia, PA: Wolter Kluwer; 2008:128-147.
24. Rothman KJ, Greenland S, Lash T. Causal diagrams. In: Modern Epidemiology. 3rd ed. Philadelphia, PA: Wolter Kluwer; 2008.
25. Miettinen OS. Stratifcation by a multivariate confounder score. Am J Epidemiol. 1976;104(6):609-620.
26. Baldwin LM, Klabunde CN, Green P, Barlow W, Wright G. In search of the perfect comorbidity measure for use with administrative claims data: does it exist? Med Care. 2006;44(8):745-753.
27. Poses RM, McClish DK, Smith WR, Bekes C, Scott WE. Prediction of survival of critically ill patients by admission comorbidity. J Clin Epidemiol. 1996;49(7):743-747.
28. Goldstein LB, Samsa G P, Matchar DB, Horner RD. Charlson Index comorbidity adjustment for ischemic stroke outcome studies. Stroke. 2004;35(8):1941-1945.
29. Lee DS, Donovan L, Austin PC, et al. Comparison of coding of heart failure and comorbidities in administrative and clinical data for use in outcomes research. Med Care. 2005;43(2):182-188.
30. Myers R P, Quan H, Hubbard JN, Shaheen AA, Kaplan GG. Predicting in-hospital mortality in patients with cirrhosis: results differ across risk adjustment methods. Hepatology. 2009;49(2):568-577.
31. Quach S, Hennessy DA, Faris P, Fong A, Quan H, Doig C. A comparison between the APACHE II and Charlson Index Score for predicting hospital mortality in critically ill patients. BMC Health Serv Res. 2009;9:129.
32. Hemmelgarn BR, Manns BJ, Quan H, Ghali WA. Adapting the Charlson Comorbidity Index for use in patients with ESRD. Am J Kidney Dis. 2003;42(1):125-132.
33. Lash TL, Mor V, Wieland D, Ferrucci L, Satariano W, Silliman RA. Methodology, design, and analytic techniques to address measurement of comorbid disease. J Gerontol A Biol Sci Med Sci. 2007; 62(3):281-285.